This study investigated anti-inflammatory effects and possible mechanisms of Chikusetsusaponin IVa (Chi IVa), one of the main bioactive components in saponins from Panacis japonica (SPJ), which is used in traditional Tujia and Hmong Chinese medicine. To this end, changes in the inflammatory profiles of lipopolysacchride (LPS)-stimulated phrobol 12-myristate 13-acetate(PMA)-differented THP-1 macrophages were evaluated following Chi IVa treatment. The results showed that Chi IVa markedly decreased the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) at both the mRNA and protein level, which proved to be dose-dependent. Further studies revealed that Chi IVa strongly suppressed NF-κB activation and downregulated the phosphorylation of ERK, p38, and JNK. Our present study demonstrates that Chi IVa suppresses the production of iNOS, COX-2, IL-1β, IL-6, and TNF-α in LPS-stimulated THP-1 cells likely by inhibiting NF-κB activation and ERK, JNK, and p38 signal pathway phosphorylation.
TabasIGlassCK (2013) Anti-inflammatory therapy in chronic disease: Challenges and opportunities. Science339: 166–172.
2.
MoilanenE (2014) Two faces of inflammation: An immunopharmacological view. Basic & Clinical Pharmacology & Toxicology114: 2–6.
3.
ChonHChoiBLeeE, et al. (2009) Immunomodulatory effects of specific bacterial components of Lactobacillus plantarum KFCC11389P on the murine macrophage cell line RAW 264.7. Journal of Applied Microbiology107: 1588–1597.
4.
BrownKLCosseauCGardyJL, et al. (2007) Complexities of targeting innate immunity to treat infection. Trends in Immunology28: 260–266.
5.
ZhangWJWeiHHagenT, et al. (2007) Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proceedings of the National Academy of Sciences of the Unites States of America104: 4077–4082.
6.
ChenLGLiuJSHuangQ (2009) The primary efficacy and mechanism of Panax japonicus. China Journal of Traditional Chinese Medicine and Pharmacy24: 197–198.
7.
HeHXuJXuY, et al. (2012) Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats. Journal of Ethnopharmacology140: 73–82.
8.
YamaharaJKubomuraYMikiK, et al. (1987) Anti-ulcer action of Panax japonicus rhizome. Journal of Ethnopharmacology19: 95–101.
9.
LiYGJiDFZhongS, et al. (2010) Saponins from Panax japonicus protect against alcohol-induced hepatic injury in mice by up-regulating the expression of GPX3, SOD1 and SOD3. Alcohol and Alcoholism45: 320–331.
10.
ZhangHWangHFLiuY, et al. (2014) The haematopoietic effect of Panax japonicus on blood deficiency model mice. Journal of Ethnopharmacology154: 818–824.
11.
HanLKZhengYNYoshikawaM, et al. (2005) Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complementary and Alternative Medicine5: 9.
12.
YuanDWanJZDengLL, et al. (2014) Chikusetsu saponin V attenuates MPP+-induced neurotoxicity in SH-SY5Y cells via regulation of Sirt1/Mn-SOD and GRP78/Caspase-12 pathways. International Journal of Molecular Sciences15: 13209–13222.
13.
Hosono-NishiyamaKMatsumotoTKiyoharaH, et al. (2006) Suppression of Fas-mediated apoptosis of keratinocyte cells by chikusetsusaponins isolated from the roots of Panax japonicus. Planta Medica72: 193–198.
14.
DahmerTBergerMBarletteAG, et al. (2012) Antithrombotic effect of chikusetsusaponin IVa isolated from Ilex paraguariensis (Maté). Journal of Medicinal Food15: 1073–1080.
15.
RattanathongkomALeeJBHayashiK, et al. (2009) Evaluation of chikusetsusaponin IVa isolated from Alternanthera philoxeroides for its potency against viral replication. Planta Medica75: 829–835.
16.
AhnCBJeJY (2012) Anti-inflammatory activity of the oriental herb medicine, Arisaema cum Bile, in LPS-induced PMA-differentiated THP-1 cells. Immunopharmacology and Immunotoxicology34: 379–384.
17.
MartinezFOSicaAMantovaniA, et al. (2008) Macrophage activation and polarization. Frontiers in Bioscience13: 453–461.
18.
KhanKNKitajimaMHirakiK, et al. (2009) Toll-like receptors in innate immunity: Role of bacterial endotoxin and toll-like receptor 4 in endometrium and endometriosis. Gynecologic and Obstetric Investigation68: 40–52.
19.
ButcharJPParsaKVMarshCB, et al. (2006) Negative regulators of toll-like receptor 4-mediated macrophage inflammatory response. Current Pharmaceutical Design12: 4143–4153.
20.
PalacioJRMarkertURMartínezP (2011) Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflammation Research60: 695–704.
21.
PaigeJSJaffreySR (2007) Pharmacologic manipulation of nitric oxide signaling: Targeting NOS dimerization and protein-protein interactions. Current Topics in Medicinal Chemistry7: 97–114.
22.
WangHWWuTQiJY, et al. (2013) Salidroside attenuates LPS-stimulated activation of THP-1 cell-derived macrophages through down-regulation of MAPK/NF-kB signaling pathways. Journal of Huazhong University of Science and Technology: Medical Sciences33: 463–469.
23.
ChengCFPanTM (2011) Protective effect of Monascus-fermented red mold rice against alcoholic liver disease by attenuating oxidative stress and inflammatory response. Journal of Agricultural and Food Chemistry59: 9950–9957.
24.
WanFLenardoMJ (2010) The nuclear signaling of NF-kappaB: Current knowledge, new insights, and future perspectives. Cell Research20: 24–33.
25.
WangSLiuZWangL, et al. (2009) NF-kappaB signaling pathway, inflammation and colorectal cancer. Cellular & Molecular Immunology6: 327–334.
26.
CorbettaSVicentiniLFerreroS, et al. (2005) Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors. Endocrine-Related Cancer12: 929–937.
27.
MorrisMCGilliamEALiL (2015) Innate immune programing by endotoxin and its pathological consequences. Frontiers in Immunology5: 1–8.
28.
ShinJSNohYSLeeYS, et al. (2011) Arvelexin from Brassica rapa suppresses NF-κB-regulated pro-inflammatory gene expression by inhibiting activation of IκB kinase. British Journal of Pharmacology164: 145–158.
29.
ArthurJSLeySC (2013) Mitogen-activated protein kinases in innate immunity. Nature Reviews Immunology13: 679–692.
30.
LeeAKSungSHKimYC, et al. (2003) Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation. British Journal of Pharmacology139: 11–20.
31.
Marks-KonczalikJChuSCMossJ (1998) Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. Journal of Biological Chemistry273: 22201–22208.
